IL22 and liver dysplastic nodule: Further investigation into multiple biological functions of IL-22, including glycemic control, metabolic regulation, anti-inflammation, and anti-fibrosis, may ultimately help us to identify IL-22 as a novel therapeutic agent for the treatment of DN.